Overview on desonide 0.05%: a clinical safety profile.
Journal of Drugs in Dermatology › Vol. 3 Nbr. 4, July 2004
Linked as:
Summary
ARTICLES
See the full content of this document
Extract
Overview on desonide 0.05%: a clinical safety profile.
Abstract
Desonide (as a cream, ointment, or lotion formulation) is widely used for the treatment of steroid-responsive dermatoses. This paper provides information on its safety record, as determined from adverse event reports and published trial results. A pharmacovigilance program, initiated in 1992 for all countries where desonide is available, collected reports of adverse events associated with topical desonide over nine years. Published accounts of randomized, controlled trials of desonide in comparison with hydrocortisone were reviewed. Sixty-two reports have been collected; most were from consumers and were not medically substantiated. There were no serious reactions directly attributable to desonide treatment and the majority of events reported were classified as expected local reactions, generally mild in nature. This level of reporting is against a background of extensive prescribing of desonide; almost one million packs are...See the full content of this document
Sponsored links
